Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study,Alzheimer's & Dementia

当前位置： X-MOL 学术 › Alzheimers Dement. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study
Alzheimer's & Dementia ( IF 13.0 ) Pub Date : 2020-01-06 , DOI: 10.1016/j.jalz.2019.07.018
Frederic Brosseron _{1,

2} , Carl-Christian Kolbe ₃ , Francesco Santarelli _{1,

2} , Stephanie Carvalho ₄ , Anna Antonell ₅ , Sergio Castro-Gomez ₁ , Pawel Tacik ₁ , Aishwarya Alex Namasivayam ₆ , Graziella Mangone ₄ , Reinhard Schneider ₆ , Eicke Latz _{2,

3} , Ullrich Wüllner _{2,

7} , Per Svenningsson ₈ , Raquel Sánchez-Valle ₅ , José Luis Molinuevo ₉ , Jean-Christophe Corvol ₄ , Michael T Heneka _{1,

2} ,

Affiliation

Department of Neurodegenerative Diseases & Geropsychiatry/Neurology, University of Bonn Medical Center, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
University of Bonn Medical Center, Institute of Innate Immune, Bonn, Germany.
Institut du Cerveau et de la Moelle épinière, Sorbonne Université, Assistance-Publique Hôpitaux de Paris, INSERM, UMRS 1127, CNRS, UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Hôpital Pitié-Salpêtrière, Department of Neurology, Centre d'Investigation Clinique Neurosciences, Paris, France.
Alzheimer's disease and other cognitive disorders Unit, Hospital Clínic, Fundació Clínic per a la Recerca Biomèdica, Institut d'Investigacions Biomè; diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Campus Belval, Belvaux, Luxembourg.
Department of Neurology, University of Bonn Medical Center, Bonn, Germany.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.

Multiple immunity biomarkers have been suggested as tracers of neuroinflammation in neurodegeneration. This study aimed to verify findings in cerebrospinal fluid (CSF) samples of Alzheimer's disease (AD) and Parkinson's disease (PD) subjects from the network of the European, Innovative Medicines Initiative–funded project AETIONOMY.

中文翻译：